ARCHIVES

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Data Presented At Scientific Meetings Can Have Impact On Patient Treatment

March 31, 2006

NCI Advisors Approve New $5 Million Program For Reagent Contracts.

July 10, 2009

Shift Of $6.5 Million From Contracts to Pay Core, P01s At Recommended Levels, Increase R01 Payline

June 27, 1980

Oxford University Press Wins CRADA For Journal Of The National Cancer Istitute

September 20, 1996

FDA, HCFA Form Council On Biomedical Imaging.

November 10, 2000

NIH Returns to Play Catch Up “After 16 Costly, Wasteful Days”

October 18, 2013